Tuesday, December 16, 2014 12:23:41 PM
Dec 16, 2014 Attorney Letter with Respect to Current Information Dec 31, 2013 Active
Dec 16, 2014 Annual Report - Corrected Dec 31, 2013 Active
Dec 16, 2014 Annual Report - Corrected Dec 31, 2013 Active
Dec 16, 2014 Quarterly Report Jun 30, 2014 Active
Dec 16, 2014 Quarterly Report - Corrected Jun 30, 2014 Active
Dec 16, 2014 Attorney Letter with Respect to Current Information Dec 31, 2013 Active
Nov 14, 2014 Quarterly Report Sept 30, 2014 Active
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM